BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15325950)

  • 1. Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography.
    Aquilante CL; Humma LM; Yarandi HN; Andrisin TE; Lewis JF; Hamilton KK; Johnson JA
    Am J Cardiol; 2004 Aug; 94(4):535-8. PubMed ID: 15325950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of high-dose dobutamine are not prevented by normal saline infusion in dobutamine stress echocardiography.
    Hecker T; De Pasquale CG; Perry R; Brown L; Koutsounis H; Joseph MX
    Echocardiography; 2008 Aug; 25(7):712-6. PubMed ID: 18445058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
    Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
    Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and predictors of complications with a new accelerated dobutamine stress echocardiography protocol.
    San Román JA; Sanz-Ruiz R; Ortega JR; Pérez-Paredes M; Rollán MJ; Muñoz AC; Segura F; Jimenez D; Carnero A; Pinedo M; Arnold R; Gómez I; Fernández-Aviles F
    J Am Soc Echocardiogr; 2008 Jan; 21(1):53-7. PubMed ID: 17628422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
    Elhendy A; Sozzi F; van Domburg RT; Bax JJ; Schinkel AF; Roelandt JR; Poldermans D
    Am J Cardiol; 2005 Aug; 96(4):469-73. PubMed ID: 16098295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in chronotropic and hemodynamic responses during dobutamine-atropine stress echocardiography.
    Tsutsui JM; Falcão SN; Dourado PM; Lima MF; Alves AA; Guerra VC; Ramires JA; Mathias W
    Echocardiography; 2007 Sep; 24(8):843-50. PubMed ID: 17767535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
    Puddu PE; Papalia U; Schiariti M; Usta C;
    Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium.
    Rizzello V; Poldermans D; Biagini E; Schinkel AF; van Domburg R; Elhendy A; Vourvouri EC; Bountioukos M; Lombardo A; Krenning B; Roelandt JR; Bax JJ
    Heart; 2005 Mar; 91(3):319-23. PubMed ID: 15710710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography.
    Biagini E; Schinkel AF; Rizzello V; van Domburg RT; Pedone C; Elhendy A; Krenning BJ; Bountioukos M; Vourvouri EC; Branzi A; Rapezzi C; Simoons ML; Bax JJ; Poldermans D
    Am J Cardiol; 2004 Oct; 94(7):954-7. PubMed ID: 15464688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.
    Jahnke C; Nagel E; Gebker R; Kokocinski T; Kelle S; Manka R; Fleck E; Paetsch I
    Circulation; 2007 Apr; 115(13):1769-76. PubMed ID: 17353441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the standard weight-based dosing of dobutamine for stress testing appropriate for patients of widely varying body mass index?
    Kittipovanonth M; Bernheim AM; Scott CG; Barnes ME; Shub C; Pellikka PA
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):173-7. PubMed ID: 21183730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress echocardiography: abnormal response of tissue Doppler-derived indices to dobutamine in the absence of obstructive coronary artery disease in patients with chronic renal failure.
    Jassal DS; Neilan TG; Picard MH; Wood MJ
    Echocardiography; 2007 Jul; 24(6):580-6. PubMed ID: 17584197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation.
    Bacal F; Moreira L; Souza G; Rodrigues AC; Fiorelli A; Stolf N; Bocchi E; Bellotti G; Ramires JA
    J Heart Lung Transplant; 2004 Nov; 23(11):1238-44. PubMed ID: 15539121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient dobutamine-mediated pulsus alternans.
    Kahn JH; Starling MR; Supiano MA
    Can J Cardiol; 2001 Feb; 17(2):203-5. PubMed ID: 11223491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic performance of the Ultracor and Carpentier-Edwards aortic prostheses using exercise and dobutamine stress echocardiography.
    Hobson NA; Wilkinson GA; Wheeldon NM; Lynch J
    J Heart Valve Dis; 2005 Nov; 14(6):828-34. PubMed ID: 16359066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of dobutamine on renal sympathetic activity in human heart failure.
    Al-Hesayen A; Parker JD
    J Cardiovasc Pharmacol; 2008 May; 51(5):434-6. PubMed ID: 18398381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):391-8. PubMed ID: 1520649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.